Literature DB >> 22798349

The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line.

Kenji Oki1, Maria W Plonczynski, Milay Luis Lam, Elise P Gomez-Sanchez, Celso E Gomez-Sanchez.   

Abstract

Angiotensin II (A-II) regulation of aldosterone secretion is initiated by inducing cell membrane depolarization, thereby increasing intracellular calcium and activating the calcium calmodulin/calmodulin kinase cascade. Mutations in the selectivity filter of the KCNJ5 gene coding for inward rectifying potassium channel (Kir)3.4 has been found in about one third of aldosterone-producing adenomas. These mutations result in loss of selectivity of the inward rectifying current for potassium, which causes membrane depolarization and opening of calcium channels and activation of the calcium calmodulin/calmodulin kinase cascade and results in an increase in aldosterone secretion. In this study we show that A-II and a calcium ionophore down-regulate the expression of KCNJ5 mRNA and protein. Activation of Kir3.4 by naringin inhibits A-II-stimulated membrane voltage and aldosterone secretion. Overexpression of KCNJ5 in the HAC15 cells using a lentivirus resulted in a decrease in membrane voltage, intracellular calcium, expression of steroidogenic acute regulatory protein, 3-β-hydroxysteroid dehydrogenase 3B2, cytochrome P450 11B1 and cytochrome P450 11B2 mRNA, and aldosterone synthesis. In conclusion, A-II appears to stimulate aldosterone secretion by depolarizing the membrane acting in part through the regulation of the expression and activity of Kir3.4.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22798349      PMCID: PMC3423613          DOI: 10.1210/en.2012-1241

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Secretagogue-induced exocytosis recruits G protein-gated K+ channels to plasma membrane in endocrine cells.

Authors:  K Morishige; A Inanobe; Y Yoshimoto; H Kurachi; Y Murata; Y Tokunaga; T Maeda; Y Maruyama; Y Kurachi
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

2.  Differential involvement of cytoskeleton and rho-guanosine 5'-triphosphatases in growth-promoting effects of angiotensin II in rat adrenal glomerulosa cells.

Authors:  Mélissa Otis; Nicole Gallo-Payet
Journal:  Endocrinology       Date:  2006-08-17       Impact factor: 4.736

3.  Identification of G protein-coupled, inward rectifier potassium channel gene products from the rat anterior pituitary gland.

Authors:  K A Gregerson; T P Flagg; T J O'Neill; M Anderson; O Lauring; J S Horel; P A Welling
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

4.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

5.  Ca(2+)-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases.

Authors:  V Pezzi; C D Clyne; S Ando; J M Mathis; W E Rainey
Journal:  Endocrinology       Date:  1997-02       Impact factor: 4.736

6.  A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.

Authors:  David S Geller; Junhui Zhang; Max V Wisgerhof; Cedric Shackleton; Michael Kashgarian; Richard P Lifton
Journal:  J Clin Endocrinol Metab       Date:  2008-05-27       Impact factor: 5.958

7.  Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion.

Authors:  Damian G Romero; Ming Yi Zhou; Licy L Yanes; Maria W Plonczynski; Tanganika R Washington; Celso E Gomez-Sanchez; Elise P Gomez-Sanchez
Journal:  J Endocrinol       Date:  2007-08       Impact factor: 4.286

8.  Development of an adrenocorticotropin-responsive human adrenocortical carcinoma cell line.

Authors:  Jeniel Parmar; Rebecca E Key; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2008-08-19       Impact factor: 5.958

9.  The production of monoclonal antibodies against aldosterone.

Authors:  C E Gomez-Sanchez; M F Foecking; M W Ferris; M R Chavarri; L Uribe; E P Gomez-Sanchez
Journal:  Steroids       Date:  1987-06       Impact factor: 2.668

10.  Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline.

Authors:  John W Funder; Robert M Carey; Carlos Fardella; Celso E Gomez-Sanchez; Franco Mantero; Michael Stowasser; William F Young; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-06-13       Impact factor: 5.958

View more
  20 in total

1.  Potassium channels related to primary aldosteronism: Expression similarities and differences between human and rat adrenals.

Authors:  Andrew X Chen; Koshiro Nishimoto; Kazutaka Nanba; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2015-09-12       Impact factor: 4.102

Review 2.  Familial hyperaldosteronism type III.

Authors:  S Monticone; M Tetti; J Burrello; F Buffolo; R De Giovanni; F Veglio; T A Williams; P Mulatero
Journal:  J Hum Hypertens       Date:  2017-04-27       Impact factor: 3.012

Review 3.  Aldosterone-Producing Cell Clusters in Normal and Pathological States.

Authors:  Kei Omata; Scott A Tomlins; William E Rainey
Journal:  Horm Metab Res       Date:  2017-12-04       Impact factor: 2.936

4.  Effect of Dietary Sodium Modulation on Pig Adrenal Steroidogenesis and Transcriptome Profiles.

Authors:  Twinkle Vohra; Elisabeth Kemter; Eckhard Wolf; Tracy Ann Williams; Na Sun; Britta Dobenecker; Arne Hinrichs; Jacopo Burrello; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez; Jun Wang; Isabella-Sabrina Kinker; Daniel Teupser; Konrad Fischer; Angelika Schnieke; Mirko Peitzsch; Graeme Eisenhofer; Axel Walch; Martin Reincke
Journal:  Hypertension       Date:  2020-10-19       Impact factor: 10.190

5.  Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3.

Authors:  Celso E Gomez-Sanchez; Xin Qi; Elise P Gomez-Sanchez; Hironobu Sasano; Martin O Bohlen; Max Wisgerhof
Journal:  Mol Cell Endocrinol       Date:  2016-10-25       Impact factor: 4.102

Review 6.  Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.

Authors:  Carolina Velarde-Miranda; Elise P Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Clin Exp Pharmacol Physiol       Date:  2013-12       Impact factor: 2.557

Review 7.  Role of KCNJ5 in familial and sporadic primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; William E Rainey; Franco Veglio; Tracy Ann Williams
Journal:  Nat Rev Endocrinol       Date:  2012-12-11       Impact factor: 43.330

8.  Primary aldosteronism: a channelopathy?

Authors:  Celso E Gomez-Sanchez
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

Review 9.  Inward-rectifying potassium channelopathies: new insights into disorders of sodium and potassium homeostasis.

Authors:  Chih-Jen Cheng; Chih-Chien Sung; Chou-Long Huang; Shih-Hua Lin
Journal:  Pediatr Nephrol       Date:  2014-06-06       Impact factor: 3.714

Review 10.  Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.

Authors:  Silvia Monticone; Tobias Else; Paolo Mulatero; Tracy A Williams; William E Rainey
Journal:  Mol Cell Endocrinol       Date:  2014-09-18       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.